Zoetis Inc Q1 2023 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Ekaterina V. Knyazkova - JPMorgan Chase & Co, Research Division - Analyst : This is Ekaterina on for Chris. So first, on price increases, any feedback from the price increases in the beginning of the year? Are you seeing any pushback from veterinarians or pet owners? And any initial thoughts on how you'll be approaching price increases in 2024. And then the second question is on Diagnostics. Any thoughts on the proposed Mars, Heska acquisition and the impact that will have on the diagnostics market? Does it change Zoetis' plans in diagnostics or the investments you're making in that market. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. MAY 04, 2023 / 12:30PM, ZTS.N - Q1 2023 Zoetis Inc Earnings Call

Question: Brandon Vazquez - William Blair & Company L.L.C., Research Division - Analyst : The first one is just on guidance. You started off the year pretty strong despite kind of inventory levels, creating a little bit of noise here. But if you kind of read through that, you're looking at, I don't know, like high single digits, maybe even double-digit operational growth to start the year, reiterated guide for 6% to 8% operational growth. So the question being, basically, what would get you to that low end of that operational growth range, given the strength you're already seeing in the year if you kind of read through the noise?